Legend Biotech (LEGN) Times Interest Earned (2019 - 2025)
Legend Biotech (LEGN) posted Times Interest Earned of $3.58 for Q4 2025, down 53.54% on a QoQ basis from $7.71 in Q3 2025, and down 76.51% year-over-year from $15.25 in Q4 2024.
Legend Biotech (LEGN) Times Interest Earned (2019 - 2025) Analysis & Trends
Legend Biotech's Times Interest Earned history runs 7 years deep, the most recent figure standing at $3.58 for Q4 2025.
- Quarterly Times Interest Earned fell 76.51% year-over-year to $3.58 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.88 (up 26.17% YoY) and the FY2025 annual result came in at $6.38, up 144.55% from the prior year.
- Times Interest Earned was $3.58 for Q4 2025 at Legend Biotech, down from $7.71 in the prior quarter.
- Across five years, Times Interest Earned topped out at $25226.4 in Q4 2023 and bottomed at -$50.75 in Q2 2022.
- A 5-year average of $1401.5 and a median of $14.02 in 2024 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 87125.91% in 2023, while the deepest fall reached 165.78% in 2023.
- Legend Biotech's Times Interest Earned stood at $147.73 in 2021, then plunged by 80.42% to $28.92 in 2022, then jumped by 87125.91% to $25226.4 in 2023, then tumbled by 99.94% to $15.25 in 2024, then plunged by 76.51% to $3.58 in 2025.
- Business Quant data shows LEGN's Times Interest Earned at $3.58 in Q4 2025, $7.71 in Q3 2025, and $24.9 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 3.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | 7.71 |
| Jun 30, 2025 | 24.90 |
| Mar 31, 2025 | 20.59 |
| Dec 31, 2024 | 15.25 |
| Sep 30, 2024 | 12.78 |
| Jun 30, 2024 | 4.28 |
| Mar 31, 2024 | 11.92 |
| Dec 31, 2023 | 25,226.43 |
| Sep 30, 2023 | -1.38 |
| Jun 30, 2023 | 39.35 |
| Mar 31, 2023 | -20.90 |
| Dec 31, 2022 | 28.92 |
| Sep 30, 2022 | 10.84 |
| Jun 30, 2022 | -50.75 |
| Mar 31, 2022 | 31.77 |
| Dec 31, 2021 | 147.73 |
| Sep 30, 2021 | 600.76 |
| Jun 30, 2021 | 1,917.22 |
| Mar 31, 2021 | -1.49 |